LBelSupremacie Mains (VENTURA INTERNATIONAL LTD.,)
Welcome to the PulseAid listing for the LBel drug offered from VENTURA INTERNATIONAL LTD.,. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | VENTURA INTERNATIONAL LTD., |
| NON-PROPRIETARY NAME: | Ensulizole, Octinoxate, and Oxybenzone |
| SUBSTANCE NAME: | ENSULIZOLE; OCTINOXATE; OXYBENZONE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
| START MARKETING DATE: | 2010-08-15 |
| END MARKETING DATE: | 0000-00-00 |
LBel Supremacie Mains HUMAN OTC DRUG Details:
| Item Description | LBel Supremacie Mains from VENTURA INTERNATIONAL LTD., |
| LABELER NAME: | VENTURA INTERNATIONAL LTD., |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .15; .38; .31(g/5mL; g/5mL; g/5mL) |
| START MARKETING DATE: | 2010-08-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 14783-062_f9c27f44-9167-439a-a8bf-0280eabe477e |
| PRODUCT NDC: | 14783-062 |
| APPLICATION NUMBER: | part352 |
Other ENSULIZOLE; OCTINOXATE; OXYBENZONE Pharmaceutical Manufacturers / Labelers:
